Display options
Cite
Hogue S, Bjoerk B, Walker A, et al. Evidence-Based Market Access Value Resource: Navigating The Hurdles for A Biologic Obtaining A License In A Second Indication in Key European Countries. Value Health. 2014;17(7):A431-2doi: 10.1016/j.jval.2014.08.1099.
Hogue, S., Bjoerk, B., Walker, A., Balp, M. M., Fernandez, M., Quijano, M., Ling, C. S., & Heyes, A. E. (2014). Evidence-Based Market Access Value Resource: Navigating The Hurdles for A Biologic Obtaining A License In A Second Indication in Key European Countries. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A431-2. https://doi.org/10.1016/j.jval.2014.08.1099
Hogue, S, et al. "Evidence-Based Market Access Value Resource: Navigating The Hurdles for A Biologic Obtaining A License In A Second Indication in Key European Countries." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A431-2. doi: https://doi.org/10.1016/j.jval.2014.08.1099
Hogue S, Bjoerk B, Walker A, Balp MM, Fernandez M, Quijano M, Ling CS, Heyes AE. Evidence-Based Market Access Value Resource: Navigating The Hurdles for A Biologic Obtaining A License In A Second Indication in Key European Countries. Value Health. 2014 Nov;17(7):A431-2. doi: 10.1016/j.jval.2014.08.1099. Epub 2014 Oct 26. PMID: 27201128.
Copy Download .nbib Format: NLM
Share it on

Value Health. 2014 Nov;17(7):A431-2. doi: 10.1016/j.jval.2014.08.1099. Epub 2014 Oct 26.

Evidence-Based Market Access Value Resource: Navigating The Hurdles for A Biologic Obtaining A License In A Second Indication in Key European Countries.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

S Hogue, B Bjoerk, A Walker, M M Balp, M Fernandez, M Quijano, C S Ling, A E Heyes

Affiliations

  1. RTI-Health Solutions, Research Triangle Park, NC, USA.
  2. Novartis Pharma AG, Basel, Switzerland.
  3. University of Glasgow, Glasgow, UK.
  4. RTI Health Solutions, RTP, NC, USA.
  5. RTI Health Solutions, Manchester, UK.

PMID: 27201128 DOI: 10.1016/j.jval.2014.08.1099

[No abstract available.]

Publication Types